Peptidoglycan preparation from Bifidobacterium longum CCM 7952 mitigates allergic airway inflammation in a MyD88-dependent manner
Abstract Intranasal administration of heat-inactivated Bifidobacterium longum CCM7952 (Bl7952) alleviates allergic airway inflammation (AAI); however, the specific cell-wall components responsible for this anti-allergic effect, as well as the underlying immunological mechanism, remain unknown. In this study, the anti-allergic and immunomodulatory properties of Bl7952 cell-wall components were investigated in female BALB/c, C57BL/6, NOD2 −/− , and MyD88 −/− mice using a murine model of AAI. Four hours before each allergen (ovalbumin) application, isolated Bl7952 surface components, including slime and cell wall-derived polysaccharides, surface proteins, or a peptidoglycan preparation, were administered intranasally. Among these components, only the peptidoglycan preparation significantly down-regulated the Th2-associated immune response and eosinophil infiltration into the lungs. This effect was largely dependent on MyD88 adapter protein and independent of NOD2 receptor signaling. Furthermore, the Bl7952-derived peptidoglycan preparation altered the frequencies of antigen-presenting and T cells in the lungs of naïve mice. Thus, the peptidoglycan preparation from Bl7952 exerts prophylactic anti-allergic effects, underscoring its potential as an immunomodulator for preventing AAI.
Authors
- Umesh Kumar Gautam (ORCID: https://orcid.org/0000-0002-7490-2539)
- Dagmar Šrůtková (ORCID: https://orcid.org/0000-0003-0054-5396)
- Marcelina Joanna Pyclik (ORCID: https://orcid.org/0000-0002-2783-2830)
- Tereza Novotná (ORCID: https://orcid.org/0000-0002-2089-2216)
- Irma Schabussová (ORCID: https://orcid.org/0000-0002-2109-2640)
- Katarzyna Leszczyńska (ORCID: https://orcid.org/0000-0003-3208-9559)
- Katarzyna Pacyga-Prus (ORCID: https://orcid.org/0000-0002-9400-9297)
- Sudhanshu Shekhar (ORCID: https://orcid.org/0000-0003-3187-2496)
- Aleksandra Inić‐Kanada (ORCID: https://orcid.org/0000-0001-7854-3812)
- Martin Schwarzer (ORCID: https://orcid.org/0000-0002-1401-6578)
- Michael Thaler (ORCID: https://orcid.org/0000-0002-5332-3693)
- Viktor Černý (ORCID: https://orcid.org/0000-0003-1197-6634)
- Tereza Horníková
- Barbora Valaskova (ORCID: https://orcid.org/0000-0002-5791-6349)
- Anna Michl
- Sabina Gorska
Institutions
- Charles University (CZ)
- Czech Academy of Sciences, Institute of Microbiology (CZ)
- General University Hospital in Prague (CZ)
- Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL)
- Medical University of Vienna (AT)
- Polish Academy of Sciences (PL)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1038/s41598-026-78815-5
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Grantová Agentura České Republiky
- Austrian Science Fund
- OeAD-GmbH